Mandate

Vinge advices CapMan on acquisition of Nacka Närsjukhus Proxima

June 28, 2007

Vinge is advising funds managed by CapMan on the acquisition of Nacka Närsjukhus Proxima. Nacka Närsjukhus Proxima is a modern healthcare provider that offers specialised healthcare services from emergency unit to complex surgery within various specialities, such as orthopaedics. The company serves primarily the greater Stockholm area and the Stockholm County Council as well as other county councils in Sweden. The transaction is subject to regulatory approvals and other customary closing conditions.

The Vinge team advising CapMan includes partners Jan Byström, and Ulf Sallnäs and associates Mats Hävermark, Philip Asmar, Johanna Rutberg and Per Westman. Partner Mikael Ståhl advises CapMan on the financing of the acquisition. Partner Johan Karlsson and associate Emma Nörler provide competition law advice.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026